Drug Shortage Report for LANTUS
Report ID | 213964 |
Drug Identification Number | 02294338 |
Brand name | LANTUS |
Common or Proper name | Lantus Solostar |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | INSULIN GLARGINE |
Strength(s) | 100UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 3 ml |
ATC code | A10AE |
ATC description | INSULINS AND ANALOGUES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-12-20 |
Estimated end date | 2024-02-23 |
Actual end date | 2024-02-12 |
Shortage status | Resolved |
Updated date | 2024-02-13 |
Company comments | MANUFACTURING DELAY |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-02-13 | French | Compare |
v4 | 2024-02-13 | English | Compare |
v3 | 2023-12-21 | English | Compare |
v2 | 2023-12-20 | French | Compare |
v1 | 2023-12-20 | English | Compare |
Showing 1 to 5 of 5